Adam S DeConde1, Jess C Mace2, Joshua M Levy3, Luke Rudmik4, Jeremiah A Alt5, Timothy L Smith2. 1. Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, University of California-San Diego, San Diego, California, U.S.A. 2. Division of Rhinology and Sinus/Skull Base Surgery, Oregon Sinus Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, U.S.A. 3. Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Anterior Skull Base, Emory University Hospital, Atlanta, Georgia, U.S.A. 4. Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Calgary, Calgary, Alberta, Canada. 5. Division of Otolaryngology-Head and Neck Surgery, Rhinology-Sinus and Skull Base Surgery Program, Department of Surgery, University of Utah, Salt Lake City, Utah, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a disease process that is driven, in part, by intrinsic mucosal inflammation. Surgery plus continued medical therapy is commonly elected by medically recalcitrant, symptomatic patients. The objective was to evaluate the prevalence of nasal polyp recurrence up to 18 months after endoscopic sinus surgery (ESS) with congruent continuing medical management. STUDY DESIGN: Prospective, multicenter cohort of adult patients undergoing ESS for medically recalcitrant CRSwNP performed between August 2004 and February 2015. METHODS: All patients received baseline nasal endoscopy quantified using Lund-Kennedy grading. All patients included for final analysis provided at least 6 months of postoperative endoscopy examinations. Multivariate analysis was used to identify risk factors for polyp recurrence. RESULTS: Three hundred sixty-three CRSwNP patients having undergone ESS involving polypectomy were enrolled. A total of 244 (67%) participants had graded postoperative endoscopies with average of follow-up of 14.3 ± 7.0 months. Surgery plus postoperative medical management significantly improved endoscopy total scores at 6 months (P < .001). The recurrence of nasal polyposis 6 months after ESS was 35% (68/197), compared to 38% (48/125) after 12 months, and 40% (52/129) after 18 months. Multivariate analysis identified both prior ESS (odds ratio [OR]: 2.6, 95% confidence interval [CI]: 1.5-4.6; P = .001) and worse preoperative polyposis severity (OR: 1.4, 95% CI: 1.1-1.8; P = .016) as risk factors for recurrent polyposis. CONCLUSIONS: Polyp recurrence is common after ESS with control of polyps up to 18 months found in approximately 60% to 70% of patients. Investigation into both surgical and medical management strategies is warranted to improve upon the observed prevalence of recurrence. LEVEL OF EVIDENCE: 2c. Laryngoscope, 127:550-555, 2017.
OBJECTIVES/HYPOTHESIS: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a disease process that is driven, in part, by intrinsic mucosal inflammation. Surgery plus continued medical therapy is commonly elected by medically recalcitrant, symptomatic patients. The objective was to evaluate the prevalence of nasal polyp recurrence up to 18 months after endoscopic sinus surgery (ESS) with congruent continuing medical management. STUDY DESIGN: Prospective, multicenter cohort of adult patients undergoing ESS for medically recalcitrant CRSwNP performed between August 2004 and February 2015. METHODS: All patients received baseline nasal endoscopy quantified using Lund-Kennedy grading. All patients included for final analysis provided at least 6 months of postoperative endoscopy examinations. Multivariate analysis was used to identify risk factors for polyp recurrence. RESULTS: Three hundred sixty-three CRSwNP patients having undergone ESS involving polypectomy were enrolled. A total of 244 (67%) participants had graded postoperative endoscopies with average of follow-up of 14.3 ± 7.0 months. Surgery plus postoperative medical management significantly improved endoscopy total scores at 6 months (P < .001). The recurrence of nasal polyposis 6 months after ESS was 35% (68/197), compared to 38% (48/125) after 12 months, and 40% (52/129) after 18 months. Multivariate analysis identified both prior ESS (odds ratio [OR]: 2.6, 95% confidence interval [CI]: 1.5-4.6; P = .001) and worse preoperative polyposis severity (OR: 1.4, 95% CI: 1.1-1.8; P = .016) as risk factors for recurrent polyposis. CONCLUSIONS: Polyp recurrence is common after ESS with control of polyps up to 18 months found in approximately 60% to 70% of patients. Investigation into both surgical and medical management strategies is warranted to improve upon the observed prevalence of recurrence. LEVEL OF EVIDENCE: 2c. Laryngoscope, 127:550-555, 2017.
Authors: Roheen Raithatha; Vijay K Anand; Jess C Mace; Timothy L Smith; Madeleine R Schaberg; Gurston G Nyquist; Peter H Hwang; Brent A Senior; James A Stankiewicz; Abtin Tabaee Journal: Int Forum Allergy Rhinol Date: 2012-01-17 Impact factor: 3.858
Authors: Richard R Orlandi; Todd T Kingdom; Peter H Hwang; Timothy L Smith; Jeremiah A Alt; Fuad M Baroody; Pete S Batra; Manuel Bernal-Sprekelsen; Neil Bhattacharyya; Rakesh K Chandra; Alexander Chiu; Martin J Citardi; Noam A Cohen; John DelGaudio; Martin Desrosiers; Hun-Jong Dhong; Richard Douglas; Berrylin Ferguson; Wytske J Fokkens; Christos Georgalas; Andrew Goldberg; Jan Gosepath; Daniel L Hamilos; Joseph K Han; Richard Harvey; Peter Hellings; Claire Hopkins; Roger Jankowski; Amin R Javer; Robert Kern; Stilianos Kountakis; Marek L Kowalski; Andrew Lane; Donald C Lanza; Richard Lebowitz; Heung-Man Lee; Sandra Y Lin; Valerie Lund; Amber Luong; Wolf Mann; Bradley F Marple; Kevin C McMains; Ralph Metson; Robert Naclerio; Jayakar V Nayak; Nobuyoshi Otori; James N Palmer; Sanjay R Parikh; Desiderio Passali; Anju Peters; Jay Piccirillo; David M Poetker; Alkis J Psaltis; Hassan H Ramadan; Vijay R Ramakrishnan; Herbert Riechelmann; Hwan-Jung Roh; Luke Rudmik; Raymond Sacks; Rodney J Schlosser; Brent A Senior; Raj Sindwani; James A Stankiewicz; Michael Stewart; Bruce K Tan; Elina Toskala; Richard Voegels; De Yun Wang; Erik K Weitzel; Sarah Wise; Bradford A Woodworth; Peter-John Wormald; Erin D Wright; Bing Zhou; David W Kennedy Journal: Int Forum Allergy Rhinol Date: 2016-02 Impact factor: 3.858
Authors: Adam S DeConde; Jeffrey D Suh; Jess C Mace; Jeremiah A Alt; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2015-04-23 Impact factor: 3.858
Authors: Ward J M Videler; Cornelis M van Drunen; Freerk W van der Meulen; Wytske J Fokkens Journal: Otolaryngol Head Neck Surg Date: 2007-02 Impact factor: 3.497
Authors: Timothy L Smith; Sabrina Mendolia-Loffredo; Todd A Loehrl; Rodney Sparapani; Purushottam W Laud; Ann B Nattinger Journal: Laryngoscope Date: 2005-12 Impact factor: 3.325
Authors: Richard M Rosenfeld; David Andes; Neil Bhattacharyya; Dickson Cheung; Steven Eisenberg; Theodore G Ganiats; Andrea Gelzer; Daniel Hamilos; Richard C Haydon; Patricia A Hudgins; Stacie Jones; Helene J Krouse; Lawrence H Lee; Martin C Mahoney; Bradley F Marple; Col John P Mitchell; Robert Nathan; Richard N Shiffman; Timothy L Smith; David L Witsell Journal: Otolaryngol Head Neck Surg Date: 2007-09 Impact factor: 3.497
Authors: Jeremiah A Alt; Timothy L Smith; Rodney J Schlosser; Jess C Mace; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2014-07-30 Impact factor: 3.858
Authors: Timothy L Smith; Rodney J Schlosser; Jess C Mace; Jeremiah A Alt; Daniel M Beswick; Adam S DeConde; Kara Y Detwiller; Jose L Mattos; Zachary M Soler Journal: Int Forum Allergy Rhinol Date: 2019-06-17 Impact factor: 3.858
Authors: Daniel M Beswick; Jess C Mace; Zachary M Soler; Noel F Ayoub; Luke Rudmik; Adam S DeConde; Timothy L Smith Journal: Laryngoscope Date: 2018-05-14 Impact factor: 3.325
Authors: N R Rowan; Z M Soler; J C Mace; M P Camilon; C Palmer; R H Jones; T L Smith; R J Schlosser Journal: Rhinology Date: 2020-08-01 Impact factor: 3.681
Authors: Naweed I Chowdhury; Jess C Mace; Todd E Bodner; Jeremiah A Alt; Adam S Deconde; Joshua M Levy; Timothy L Smith Journal: Int Forum Allergy Rhinol Date: 2017-10-20 Impact factor: 3.858
Authors: Robert Naclerio; Fuad Baroody; Claus Bachert; Benjamin Bleier; Larry Borish; Erica Brittain; Geoffrey Chupp; Anat Fisher; Wytske Fokkens; Philippe Gevaert; David Kennedy; Jean Kim; Tanya M Laidlaw; Jake J Lee; Jay F Piccirillo; Jayant M Pinto; Lauren T Roland; Robert P Schleimer; Rodney J Schlosser; Julie M Schwaninger; Timothy L Smith; Bruce K Tan; Ming Tan; Elina Toskala; Sally Wenzel; Alkis Togias Journal: J Allergy Clin Immunol Pract Date: 2020-03-04